Overactivity of tumor necrosis factor-alpha but not interleukin 6 is associated with low natural killer cytotoxic activity in the elderly

Gerontology

Volumn 43, Issue 3, 1997, Pages 158-167

  Myśliwska, Jolanta ^a   Bryl, Ewa ^a   Zorena, Katarzyna ^a   Balon, Joanna ^a   Foerster, Jerzy ^b   Myśliwski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Geriatric Outpatient's Department   (Poland)

Author keywords

Ageing; Interleukin 6; Natural killer cytotoxic activity; Tumor necrosis factor alpha

Indexed keywords

INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; BLOTTING, WESTERN; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0345130874     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213845     Document Type: Article

References (30)

1. Ershler WB, Sun WH, Binkley N, Gravcnstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R: lnterleukin-6 and aging: Blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokinc Cytokine Res 1993;12:225-230.
2. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschin C, Paga-nelli R: Increased cytokine production in mononuclear cells of healthy elderly people. EurJ Immunol 1993; 23:2375-2378.
3. Mooradian AD, Reed RL, Osterwcil D, Clements N, Scuderi P: Lack of an association between the presence of tumor necrosis factor or interleukin-1-alpha in the blood and weight loss among elderly patients. JAGS 1990;38:397-410.
4. Wei J, Xu H, Davies JL, Hcmmings GP: Increase of plasma IL-6 concentration with age in healthy subjects. LifcSci 1993:51:1953.
5. Bluethmann H, Rothe J, Schultze N, Tkachuk M, Kocbcl P: Establishment of the role of 1L6 and TNF receptor 1 using gene knockout mice. J Leukoc Biol 1994:56:565-570.
6. Tracey KJ, Cerami A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503.
7. Van Snick J: Interlcukin-6: An overview. Ann Rev Immunol 1990:8: 253-278.
8. Gallagher G, Stimson WH, Findlay J, Al-Azzawi F: Interleukin 6 enhances the induction of human lym-phokinc-activated killer cells. Cancer Immunol Immunothcr 1990;31: 49-52.
9. Naume B, Shalaby R, Lesslauer W, Espevik T: Involvement of the 55 and 75-kDa tumor necrosis factor receptors in the generation of lym-phokine-activatcd killer cell activity and proliferation of natural killer cells. J Immunol 1991; 146:3045- 3048.
10. Ostcnsc M, Thiele DL, Lipsky PE: Tumor necrosis factor-a enhances cytolytic activity of human natural killer cells. J Immunol 1987; 138: 4185-4191.
11. Smyth MJ, Ortaldo JR: Comparison of the effect of IL2 and IL6 on the lytic activity of purified human peripheral blood large lymphocytes. J Immunol 1991;146:1380-1384.
12. Rabinowich H, Goses Y, Reshcf T, Klajman A: Interleukin-2 production and activity in aged humans. MechAgeDev 1985:32:213-226.
13. Guidi L, Bartoloni C, Frasca D, An-tico L, Pili R, Cursi F, Tempesta E, Rumi C, Menini E, Carboniti P: Impairment of lymphocyte activities in depressed aged subjects, Mcch Age Dev 1991;60:13-24.
14. Mysliwska J, Mysliwski A, Roma-nowski P, Bigda J, Sosnowska D, Foerstcr J: Monocytes are responsible for depressed natural killer (NK) activity in both young and elderly low NK responders. Gerontology 1992;38:41-49.
15. Mysliwska J, Bryl E, Chodnik T, Foerstcr J, Mysliwski A: Level of NK cytotoxic activity in the elderly aged more than 80 years. Arch Gerontol Geriatr 1992:15:21-28.
16. Bender BS, Chrest FJ, Adler WA: Phenotypic expression of natural killer cell associated membrane antigens and cytolytic function of peripheral blood cells from different aged humans. J Clin Lab Immunol 1986:21:31-36.
17. Krishnaraj R: Immunoscnesccncc of human NK cells: Effects on tumor target recognition, lethal hit and interferon sensitivity. Immunol Lett 1992;43:89-84.
18. Facchini A, Mariani E, Mariani AR, Papa S, Vitale M, Manzoli FA: Increased number of circulating Leu 11 + (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol 1987;68:340-347.
19. Camazzo G, Morine G, Turturici A, Favetty A, Campo ME, Consenza C, Stivala F: Pathophysiology of the immune system in the elderly subjects with or without diabetes and variations after recombinant interleukin-2. Arch Geront Geriatr 1989: 9:163-180.
20. Mariani E, Roda P, Vitale M, Dc-grassi A, Papa S, Facchini A: Age-related changes in CD8+ and CD16+ cell reactivity: Clonal analysis. Clin Exp Immunol 1990:81: 479-484.
21. Mariani E, Monaco MCG, Cattini L, Sinoppi M, Facchini A: Distribution and lytic activity of NK cell subsets in the elderly. Mech Age Dev 1994;76:177-187.
22. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kcnnes B, Muller-Hcrmelink HK, Steinmann GG: Admission criteria for immunogerontological studies in man: The Senieur protocol. Mech Age Dev 1984;28:47-55.
23. Candore G, Lorenzo L, Meliuso M, Cigna D, Colucci AT, Modica MA, Caruso C: y-Interferon, interleukin-4 and interleukin- 6 in vitro production in old subjects. Autoimmunity 1993;16:275-280.
24. Glowacki J: Influence of age on human marrow. Calcif Tissue Int 1995;56(suppl 1):SS0-S51.
25. Graeve L, Baumann M, Heinrich PC: lnlerlcukin-6 in autoimmune diseases: Role of 1L-6 in physiology and pathology of the immune defense. Clin Invest 1993;71:664-671.
26. Marie PJ, Hott M, Launay JM, Graulet AM, Gueris J: In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: Relationship with cell proliferation. J Clin Endocrinol Metab 1991;77:824-830.
27. Pacifici R, Rifas L, McCracken R, Avioli LV: The role of interleukin-1 in postmenopausal bone loss. Exp Gerontol 1990;25:309-316.
28. Fujiwara T, Grimm AE: Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist: Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction. J Immunol 1992;148: 2941-2946.
29. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri A, Ortolani C, Forti E: Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993; 82:2767-2773.
30. Krishnaraj R, Blandford G: Age-associated alterations in human natural killer cells. I. Increased activity as per conventional and kinetic analysis. Clin Immunol Immunpa-thof 1987;45:268-285.